What is King Bio?
King Bio specializes in the manufacturing of condition-specific homeopathic products, offering a diverse portfolio of over 500 medicines across six distinct brands, including SafeCareRx. The company leverages nearly four decades of expertise in integrative medicine, founded by Dr. Frank King, to empower individuals through natural healing. Beyond its own brands, King Bio also provides comprehensive contract manufacturing and private label services, catering to a broader market need for high-quality homeopathic formulations.
How much funding has King Bio raised?
King Bio has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for King Bio?
With the recent influx of capital described as a major strategic investment, King Bio is poised for significant expansion and further innovation in the rapidly growing integrative medicine market. This late-stage funding suggests a focus on scaling operations, enhancing research and development for new product lines, and potentially broadening its market reach through strategic partnerships or acquisitions. The company's established track record and commitment to natural medicine position it favorably for continued growth and leadership in the sector.
See full King Bio company page
